Literature DB >> 32526552

Epoxide containing molecules: A good or a bad drug design approach.

Ana R Gomes1, Carla L Varela2, Elisiário J Tavares-da-Silva3, Fernanda M F Roleira4.   

Abstract

Functional group modification is one of the main strategies used in drug discovery and development. Despite the controversy of being identified for many years as a biologically hazardous functional group, the introduction of an epoxide function in a structural backbone is still one of the possible modifications being implemented in drug design. In this manner, it is our intention to prove with this work that epoxides can have significant interest in medicinal chemistry, not only as anticancer agents, but also as important drugs for other pathologies. Thus, this revision paper aims to highlight the biological activity and the proposed mechanisms of action of several epoxide-containing molecules either in preclinical studies or in clinical development or even in clinical use. An overview of the chemistry of epoxides is also reported. Some of the conclusions are that effectively most of the epoxide-containing molecules referred in this work were being studied or are in the market as anticancer drugs. However, some of them in preclinical studies, were also associated with other different activities such as anti-malarial, anti-arthritic, insecticidal, antithrombotic, and selective inhibitory activity of FXIII-A (a transglutaminase). As for the epoxide-containing molecules in clinical trials, some of them are being tested for obesity and schizophrenia. Finally, drugs containing epoxide groups already in the market are mostly used for the treatment of different types of cancer, such as breast cancer and multiple myeloma. Other diseases for which the referred drugs are being used include heart failure, infections and gastrointestinal disturbs. In summary, epoxides can be a suitable option in drug design, particularly in the design of anticancer agents, and deserve to be better explored. However, and despite the promising results, it is imperative to explore the mechanisms of action of these compounds in order to have a better picture of their efficiency and safety.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer activity; Chemistry; Epoxide; Toxicity

Mesh:

Substances:

Year:  2020        PMID: 32526552     DOI: 10.1016/j.ejmech.2020.112327

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

Review 1.  Oxygen- and Sulphur-Containing Heterocyclic Compounds as Potential Anticancer Agents.

Authors:  Harshita Sachdeva; Sarita Khaturia; Mohammad Saquib; Narsingh Khatik; Abhinav Raj Khandelwal; Ravina Meena; Khushboo Sharma
Journal:  Appl Biochem Biotechnol       Date:  2022-07-28       Impact factor: 3.094

Review 2.  Revisiting the therapeutic potential of tocotrienol.

Authors:  Ranmali Ranasinghe; Michael Mathai; Anthony Zulli
Journal:  Biofactors       Date:  2022-06-20       Impact factor: 6.438

3.  Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo.

Authors:  Oksana V Salomatina; Aleksandra V Sen'kova; Arseny D Moralev; Innokenty A Savin; Nina I Komarova; Nariman F Salakhutdinov; Marina A Zenkova; Andrey V Markov
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

Review 4.  Put a ring on it: application of small aliphatic rings in medicinal chemistry.

Authors:  Matthias R Bauer; Paolo Di Fruscia; Simon C C Lucas; Iacovos N Michaelides; Jennifer E Nelson; R Ian Storer; Benjamin C Whitehurst
Journal:  RSC Med Chem       Date:  2021-01-07

5.  Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives.

Authors:  Vincent Montero; Marc Montana; Omar Khoumeri; Florian Correard; Marie-Anne Estève; Patrice Vanelle
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-23

6.  ENT-A010, a Novel Steroid Derivative, Displays Neuroprotective Functions and Modulates Microglial Responses.

Authors:  Canelif Yilmaz; Thanasis Rogdakis; Alessia Latorrata; Evangelia Thanou; Eleftheria Karadima; Eleni Papadimitriou; Eleni Siapi; Ka Wan Li; Theodora Katsila; Theodora Calogeropoulou; Ioannis Charalampopoulos; Vasileia Ismini Alexaki
Journal:  Biomolecules       Date:  2022-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.